Page 8 reads pretty well. Pain management which is the golden goose of MVP has seen good increases in sales across the board. They just need to continue this, cut costs, get into more Europe countries and land US approval.
Ann: 2024 Half Year Announcement, page-5
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 46.0¢ | 44.0¢ | $10.2K | 22.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41949 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 13548 | 3 |
View Market Depth
| Last trade - 15.47pm 04/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |